Merck To Face Propecia Sexual Dysfunction MDL

Law360, New York (April 17, 2012, 2:47 PM EDT) -- A federal judicial panel on Monday consolidated lawsuits in New York claiming Merck & Co. Inc. failed to warn users of hair loss drug Propecia that it could cause sexual dysfunction that lingers even after treatment is discontinued.

The U.S. Judicial Panel on Multidistrict Litigation bundled nine suits over the drug in the Eastern District of New York. The consolidation came days after the U.S. Food and Drug Administration expanded the labels for Propecia to warn consumers of links to libido, ejaculation and orgasm disorders after...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.